SCHEMBL22291007

SCHEMBL22291007

NC(=O)NCCC1CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 6/20 0.47
ITGA2B P08514 6/20 0.47
TPSAB1 Q15661 2/20 0.47
TPSD1 Q9BZJ3 2/20 0.47
TPSG1 Q9NRR2 2/20 0.47
TDP1 Q9NUW8 1/20 0.45
SIGMAR1 Q99720 1/20 0.43
CHRM1 P11229 2/20 0.41
ALOX15 P16050 2/20 0.41
TSHR P16473 2/20 0.41
NAMPT P43490 1/20 0.40
PRMT3 O60678 1/20 0.40
ROCK2 O75116 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM3 P20309 1/20 0.40
EPHX1 P07099 1/20 0.40
F2R P25116 2/20 0.39
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4424894 0.86
SCHEMBL1290747 0.82 ITGB3 (0.51) ITGB3ITGA2BTPSAB1TPSD1TPSG1
SCHEMBL15270205 0.82 EPHX1 (0.52) TPSAB1TPSD1TPSG1TDP1SIGMAR1
Hydrochloric Acid SCHEMBL20771047 0.81 ITGB3 (0.50) ITGB3ITGA2BTPSAB1TPSD1TPSG1
SCHEMBL1037980 0.81 ALOX15 (0.47) ITGB3ITGA2BTPSAB1TPSD1TPSG1
SCHEMBL1082190 0.81 NOS2 (0.42) ITGB3ITGA2BTPSAB1TPSD1TPSG1
SCHEMBL1440608 0.80 EPHX1 (0.59) TDP1SIGMAR1TSHREPHX1
SCHEMBL7350548 0.80 TDP1 (0.72) ITGB3ITGA2BTDP1CHRM1ALOX15
Hydrochloric Acid SCHEMBL7417264 0.79 ALOX15 (0.46) ITGB3ITGA2BTPSAB1TPSD1TPSG1
SCHEMBL16011477 0.79 ITGB3 (0.46) ITGB3ITGA2BTPSAB1TPSD1TPSG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059218-A1 ENPP1 Inhibitors and Methods of Modulating Immune Response THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2025-02-20 US disclosed
CN-113677350-B ENPP1 inhibitors and methods of modulating immune responses 里兰斯坦福初级大学理事会 2025-01-14 CN disclosed
US-20220289775-A1 ENPP1 Inhibitors and Methods of Modulating Immune Response NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-09-15 US disclosed
EP-3917536-A1 ENPP1 INHIBITORS AND METHODS OF MODULATING IMMUNE RESPONSE The Board of Trustees of the Leland Stanford Junior University (US) 2021-12-08 EP disclosed
CN-113677350-A ENPP1 inhibitors and methods of modulating immune responses 里兰斯坦福初级大学理事会 2021-11-19 CN disclosed
WO-2020160333-A1 ENPP1 INHIBITORS AND METHODS OF MODULATING IMMUNE RESPONSE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2020-08-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220289775-A1 ENPP1 Inhibitors and Methods of Modulating Immune Response ENPP1, STING1, ENPP2 ITGB3 4836/4885ITGA2B 4655/4885TPSAB1 967/4885
US-20250059218-A1 ENPP1 Inhibitors and Methods of Modulating Immune Response ENPP1, STING1, ENPP2 ITGB3 4836/4885ITGA2B 4655/4885TPSAB1 967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.